Evidence map›Paper›PMID 40103605›Full record

ArticleExploratory research in clinical and social pharmacy2025

Development of the barriers to opioid access scale among individuals with chronic pain.

Sujith Ramachandran, Stefan Kertesz, Emily Gravlee, Prachi Prajapati, John P Bentley, Yi Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sujith RamachandranDepartment of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS 38677, United States.
Stefan KerteszVeterans Affairs, Birmingham Alabama Health Care and University of Alabama at Birmingham, Birmingham, AL 35233-1927, UK.
Emily GravleeDepartment of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS 38677, United States.
Prachi PrajapatiDepartment of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS 38677, United States.
John P BentleyDepartment of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS 38677, United States.
Yi YangDepartment of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS 38677, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Measurement of accessibility is a crucial pillar in assessing equity of access to pain treatment, particularly in the context of reducing opioid prescribing in response to rising overdose deaths in the United States. Objectives: The aim of this study was to develop an instrument to measure barriers to prescription opioid access among individuals with chronic pain and test its psychometric properties. Methods: This study used a cross-sectional online survey of a convenience sample of adults (>18 years) who reported any type of pain for at least 45 days or more in the previous 3 months. The survey captured demographic characteristics, self-reported medication use characteristics, and measures such as the Brief Pain Inventory-Short Form and the PROMIS Global Health measure, along with an item pool of potential questions that measure barriers to opioid access. Results: Respondents ( Conclusions: The newly developed BOAS has the potential to serve as a tool for capturing quality of pain treatment as well as measuring the impact of policy changes on the quality of treatment provided to patients with chronic pain.

Indexed as

Barriers to opioid accessChronic painOpioid prescribingQuality of life

Identifiers

PMID40103605
PMCPMC11914507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.